Close Menu
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds

Subscribe to Updates

Get the latest markets and assets news and updates directly to your inbox.

Trending Now

Martin Parr, photographer who captured mundane details of British life, dies at 73.

December 8, 2025

ARTnews 2025 Awards Announced, Trump Kennedy Center Seizure Capped by Honors Event, and More: Morning Links for December 8, 2025

December 8, 2025

Louvre staff vote to strike, citing failures of management and building maintenance – The Art Newspaper

December 8, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
The Asset ObserverThe Asset Observer
Newsletter
LIVE MARKET DATA
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds
The Asset ObserverThe Asset Observer
Home»Stocks
Stocks

Masimo plans to split off consumer tech division By Investing.com

News RoomBy News RoomMarch 25, 2024
Share
Facebook Twitter LinkedIn Pinterest Email

© Reuters.

IRVINE, Calif. – Masimo (NASDAQ:) Corporation (NASDAQ:MASI), known for its noninvasive monitoring technologies, is considering a strategic move to separate its consumer business from its core healthcare operations.

The decision, authorized by the company’s Board of Directors, is aimed at enhancing the focus and profitability of its healthcare products while establishing a new entity for consumer audio and health products.

The proposed separation would see Masimo’s consumer-oriented products, such as the Stork baby monitor and the Freedom smart watch and band, transition to a newly formed company. Meanwhile, Masimo would continue to concentrate on its professional healthcare and telehealth solutions.

Joe Kiani, the current Chairman and CEO of Masimo, is expected to lead both the existing and the new company once the separation is complete.

The move comes as part of Masimo’s broader strategy to optimize shareholder value and provide a clearer path for growth for both segments of its business. The company is currently working through the due diligence process and aims to finalize the separation promptly, pending regulatory approvals and the completion of definitive agreements.

Masimo has also reiterated its financial guidance for the first quarter and the full fiscal year of 2024, signaling confidence in its current business trajectory.

Masimo’s reputation in the field of medical technology is underpinned by its extensive product portfolio, which includes advanced patient monitoring systems, sensors, and connectivity solutions. The company’s innovative pulse oximetry technology, Masimo SET®, has been recognized in over 100 independent studies for its superior performance.

The planned separation is subject to various conditions, including regulatory review and the approval of filings with the Securities and Exchange Commission. As the process unfolds, Masimo is committed to ensuring minimal disruption to its operations and maintaining its focus on delivering high-quality healthcare solutions.

This announcement is based on a press release statement from Masimo Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Intel, Adobe and these other ‘AI loser’ stocks could get left behind in the next phase of the tech boom

How Nvidia’s stock can benefit from this emerging trend in AI models

Why this veteran strategist is dropping his preference for tech stocks after 15 years

Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets

Opinion: Young men aren’t investing in a 401(k) for retirement — they’re banking on bitcoin

Why IBM plans to buy Confluent in its biggest deal since 2019

How to beat inflation over the next year in one investing move

Opinion: Bitcoin’s November crash was no accident

Just weeks before Buffett retires, Berkshire makes a number of leadership changes

Recent Posts
  • Martin Parr, photographer who captured mundane details of British life, dies at 73.
  • ARTnews 2025 Awards Announced, Trump Kennedy Center Seizure Capped by Honors Event, and More: Morning Links for December 8, 2025
  • Louvre staff vote to strike, citing failures of management and building maintenance – The Art Newspaper
  • FCA eyes introduction of standardised disclosure for MPS
  • Intel, Adobe and these other ‘AI loser’ stocks could get left behind in the next phase of the tech boom

Subscribe to Newsletter

Get the latest markets and assets news and updates directly to your inbox.

Editors Picks

ARTnews 2025 Awards Announced, Trump Kennedy Center Seizure Capped by Honors Event, and More: Morning Links for December 8, 2025

December 8, 2025

Louvre staff vote to strike, citing failures of management and building maintenance – The Art Newspaper

December 8, 2025

FCA eyes introduction of standardised disclosure for MPS

December 8, 2025

Intel, Adobe and these other ‘AI loser’ stocks could get left behind in the next phase of the tech boom

December 8, 2025

ARTnews Awards 2025 Best Thematic Museum Show: “Legacies: Asian American Art Movements in New York City”

December 8, 2025
Facebook X (Twitter) Instagram
© 2025 The Asset Observer. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.